University of Washington spinout AltPep will use the proceeds from the Alexandria Venture Investments-backed round to advance a lead asset targeting Alzheimer’s disease.
AltPep, a US-based developer of misfolded protein treatment and diagnostics technology, has closed a $23.1m series A round featuring life sciences real estate investment trust Alexandria Real Estate Equities (AREE). The round was led by investment management firm Matrix Capital Management while AREE participated through its venture capital arm, Alexandria Venture Investments. Founded in 2018,…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.